DEV Community


Posted on

Molecular Diagnostics Market 2021-2030 Size and Share, Recent Enhancements and Regional Analysis

Absolute Markets Insights has recently added an extensive report to its repository titled Molecular Diagnostics market. The latest market study provides a lucid understanding of the Molecular Diagnostics sector and the report scrutinizes the data by using primary and secondary research techniques. Moreover, it also sheds light on various dynamic aspects of businesses such as client requirements, demanding products or services, shares, and raw material. Additionally, the data has been examined by means of effective analysis technique such as, SWOT and Porter’s Five analysis. This in return also gives a descriptive overview of strengths, weaknesses, threats, and opportunities.

The study especially focuses on widespread global regions such as North America, Latin America, Asia-Pacific, Europe, and India on the basis of the manufacturing base, productivity, and profit margin. Moreover, the market scope has been analyzed on the basis of different practical oriented case studies from various industry experts and policymakers. For the analysis, the report uses numerous graphical presentation techniques such as tables, charts, graphs, pictures and flowchart for easy and better understanding to the readers. Economic aspects of the businesses have been presented by providing significant facts and figures which deliver a financial overview of the business process.

Key Topics Covered:

Introduction, Research & Methodology, Executive Summary, Market Dynamic, Market Share Analysis, Source Type Market, Product Type Market, Industry Market, Regional Segmentation

Global Molecular Diagnostics Market was valued at US$ 8750.32 million in 2020 and is expected to reach US$ 16359.76+ million by 2030, growing at an estimated CAGR of +7.2% over the forecast period.

Please click the link below to get a full report:

The molecular diagnostics market has been split into genetic tests, infectious diseases, oncology and others. Over recent years, the use of molecular diagnostics has increased, and what once was a technique reserved for specialist centers is now in common use in most diagnostic labs. Comprehensive molecular diagnostics have now become a standard of even simple laboratories, treating diseases such as influenza, human immunodeficiency viruses, methicillin-resistant Staphylococcus aureus, including the ability to diagnose drug resistance. The key use remains in the world of virology, where molecular diagnostics have been able to replace long cultivation methods which allow safe and fast diagnosis. Genetic research aids in the discovery of genetic and chromosomal variations associated with disease and risk conditions. Molecular diagnostics consist of sophisticated laboratory tools in which genetic sequences, biomarkers, metabolites and other molecules are detected and analyzed.

Key Players Operating in Global Molecular Diagnostics Market: Roche Diagnostics; Abbott; Bio-Rad Laboratories, Inc.; Siemens Healthcare GmbH; Alere, Inc.; Bayer AG; Dako; Hologic, Inc. (Gen probe); Sysmex Corporation; Danaher; Johnson & Johnson; Novartis AG; Qiagen N.V.; Becton, Dickinson and Company; Cepheid; and bioMerieux SA.

Global Molecular Diagnostics Market: Key Segmentation

Products and Services

Reagents and Kits
Software and Services
By Application

Genetic Tests
Infectious Diseases
By Technology

DNA Sequencing & NGS
In Situ Hybridization
DNA Microarrays
By End-user

Diagnostic Laboratories
By Region:

North America
Asia Pacific
Middle East and Africa
Latin America
Contact Us:

Company: Absolute Markets Insights

Email id:

Phone: +91-740-024-2424

Contact Name: Shreyas Tanna


Discussion (0)